These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15416069)

  • 1. A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
    MATTHEWS WB
    Lancet; 1950 May; 1(6611):896-9. PubMed ID: 15416069
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
    GARDIKAS C; WILKINSON JF
    Lancet; 1951 Jan; 1(6647):137-9. PubMed ID: 14795794
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of CB 1348 in Hodgkin's disease and allied disorders.
    BOURONCLE BA; DOAN CA; WISEMAN BK; FRAJOLA WJ
    AMA Arch Intern Med; 1956 Jun; 97(6):703-14. PubMed ID: 13312712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia].
    RAMIOUL H
    Acta Unio Int Contra Cancrum; 1955; 11(2):167-9. PubMed ID: 13248724
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrogen mustards in the treatment of neoplastic disease.
    KARNOFSKY DA
    Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
    BARENGHI G
    Accad Medica; 1950 Dec; 65(12):506-27. PubMed ID: 14856512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
    de LORENZO J; JANNINI P
    Arq Clin (Rio De J); 1951 Mar; 12(3):141-61. PubMed ID: 14847898
    [No Abstract]   [Full Text] [Related]  

  • 8. Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.
    LARIONOV LF
    Br Med J; 1956 Feb; 1(4961):252-6. PubMed ID: 13276690
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.
    VIDEBAEK A; KAAE S
    Acta Med Scand; 1954; 149(5):361-8. PubMed ID: 13180246
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Oct; 134():374-88. PubMed ID: 13976141
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    GOODMAN LS; WINTROBE MM
    J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
    SAMPEY JR
    J S C Med Assoc (Columbia); 1963 Aug; 59():272-4. PubMed ID: 13976136
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of lymphogranuloma malignum and related conditions with methyl bis-chloroethylamine (nitrogen mustard)].
    GROEN J; GODFRIED EG
    Ned Tijdschr Geneeskd; 1949 Aug; 93(32):2681-9. PubMed ID: 18141966
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral treatment of polycythaemia vera with beta-naphthyl-di-2-chloroethylamine (R48).
    IVERSEN K; MEULENGRACHT E
    Br Med J; 1951 Sep; 2(4730):510-3. PubMed ID: 14869628
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial of a new nitrogen-mustard compound.
    SELLEI C; ECKHARDT S; HARTAI F; DUMBOVICH B
    Lancet; 1956 May; 270(6926):785-6. PubMed ID: 13320884
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta Radiol (Stockh); 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
    LEVI M; MENE G; FERRI A
    Riv Patol Clin; 1951 Jan; 6(1):1-58. PubMed ID: 14834735
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR
    J S C Med Assoc (Columbia); 1962 May; 58():175-6. PubMed ID: 14496660
    [No Abstract]   [Full Text] [Related]  

  • 19. CB 1348 therapy in leukemia and allied diseases.
    SAMPEY JR
    Am Pract Dig Treat; 1959 Aug; 10():1361-4. PubMed ID: 14441245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nitrogen mustard therapy of malignant tumors].
    LINDEMANN M; GUMMEL H
    Dtsch Gesundheitsw; 1950 Nov; 5(48):1506-15. PubMed ID: 14793092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.